Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/USP meeting

Executive Summary

U.S. Pharmacopeial's Executive Committee for Drug Standards met Oct. 26 with FDA Center for Drug Evaluation and Research Deputy Director Gerald Meyer, Office of Drug Standards Director Peter Rheinstein, MD, and Compendial Operations Branch Chief Joel Davis to discuss drug standard issues. It was the first time the exec committee has met with Meyer and Rheinstein, according to FDA.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014555

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel